Greetings from Israel. Moni and Fred are at a working lunch with the ZipThaw and ZipSleeve production engineering team atf Aran R&D.
(more…)
Greetings from Israel. Moni and Fred are at a working lunch with the ZipThaw and ZipSleeve production engineering team atf Aran R&D.
(more…)
Dr. Viscomi, Moni and I thank you for your confidence and investment in FreMon Scientific. 2018 portends manufacturing and sales. Your 2017 investment resulted in the following achievements:
From: FreMon Scientific, Inc (FMS) – Fred Thacher, CEO
Subject: Recent FDA, CE Mark, Production Engineering and Finance Activities
Date: November 15, 2017, by Fred Thacher FMS CEO and Co-Founder
Last week: Moni and I met in Israel with the FDA/CE Mark agent Qsite and with Mintz Levin FDA attorney to review production engineering requirements for compliance.
FreMon Scientific has successfully completed a first round financing resulting in a working prototype blood, plasma and tissue warming and thawing device.
(more…)
The New York Blood Center (NYBC) trial group completed testing FreMon Scientific’s new blood, plasma and tissue products warming and thawing device and disposable: ZipThaw202™ and ZipSleeve™. (more…)
FreMon Scientific accepted final delivery of the ZipThaw202™ prototype from Sysmop Technologies of Israel at the New York Blood Center on August 17th 2017.
(more…)